Mechanisms of signal transduction activated by sublytic assembly of terminal complement complexes on nucleated cells

Immunologic Research

Volumn 24, Issue 2, 2001, Pages 191-199

  Niculescu, F ^a   Rus, H ^a  

^a UNIVERSITY OF MARYLAND   (United States)

Author keywords

Complement Activation; Complexes B; Endothelial Cells; ERK1; Lymphocytes; PI 3 Kinase; Smooth Muscle Cells; STAT3; Terminal Complement

Indexed keywords

COMPLEMENT; COMPLEMENT COMPONENT C5B 7; COMPLEMENT COMPONENT C5B 8; COMPLEMENT MEMBRANE ATTACK COMPLEX; CYTOKINE; GUANINE NUCLEOTIDE BINDING PROTEIN; LEUKOTRIENE; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOLIPASE; PROSTANOID; RAF PROTEIN; RAS PROTEIN; STAT3 PROTEIN; TERMINAL COMPLEMENT COMPLEX; UNCLASSIFIED DRUG;

ARTICLE; B LYMPHOCYTE; CELL ACTIVITY; CELL NUCLEUS; CELL PROLIFERATION; CELL SURVIVAL; COMPLEMENT ACTIVATION; CYTOLYSIS; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; INFLAMMATION; MITOSIS; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER;

AORTA; B-LYMPHOCYTES; COMPLEMENT ACTIVATION; COMPLEMENT C5; COMPLEMENT MEMBRANE ATTACK COMPLEX; COMPLEMENT SYSTEM PROTEINS; ENDOTHELIUM, VASCULAR; HUMANS; LYMPHOCYTE ACTIVATION; MUSCLE, SMOOTH, VASCULAR; SIGNAL TRANSDUCTION;

EID: 0034838024     PISSN: 0257277X     EISSN: None     Source Type: Journal    
DOI: 10.1385/IR:24:2:191     Document Type: Article

References (66)

1. Molecular organization and function of the complement system
2. Membrane attack by complement: Assembly and biology of terminal complement complexes
3. Complement membrane attack on nucleated cells: Resistance, recovery and non-lethal effects
4. The membrane attack mechanism of complement: Photolabeling reveals insertion of terminal proteins into target membrane
5. Recovery of human neutrophils from complement attack: Removal of the membrane attack complex by endocytosis and exocytosis
6. 2+
7. 2+-initiated activation of cellular protein kinases
8. Membrane vesiculation protects erythrocytes from destruction by complement
9. Sublytic complement attack induces cell cycle in oligodendrocytes. S phase induction is dependent on c-jun activation
10. Terminal complement complex C5b-9 stimulates mitogenesis in 3T3 cells
11. Terminal complement proteins C5b-9 release basic fibroblast growth factor and platelet-derived growth factor from endothelial cells
12. Multiple signal messengers generated by terminal complement complexes and their role in terminal complement complex elimination
13. Generation of diacylglycerol and ceramide during homologous complement activation
14. Receptor-independent activation of guanine nucleotide-binding regulatory proteins by terminal complement complexes
15. G-protein-coupled receptors and their regulation: Activation of MAP kinase signaling pathway by G-protein-coupled receptors, Adv.
16. Mitogenic signaling via G-protein-coupled receptors
17. Specificity or receptor tyrosine kinase signaling: Transient versus sustained extracellular signal-regulated kinase activation
18. Transcriptional regulation by extracellular signals: Mechanisms and specificity
19. Protein kinases and phosphatases: The yin and yang of protein phosphorylation and signaling
20. Ras-dependent activation of MAP kinase pathway mediated by G-protein βγ subunits
21. ras
22. cAMP and βγ subunits of heterotrimeric G proteins stimulate the mitogen-activated protein kinase pathway in Cos-7 cells
23. Distinct pathways of Gi- and Gq-mediated mitogen-activated protein kinase activation
24. Receptor-tyrosin-kinase- and Gβγ-mediated MAP kinase activation by a common signalling pathway
25. Go-protein α-subunits activate mitogen-activated protein kinase via a novel protein kinase C-dependent mechanism
26. A direct interaction between G-protein βγ subunits and the Raf-1 protein kinase
27. Cellular expression of the carboxyl terminus of a G protein-coupled receptor kinase attenuates Gβγ-mediated signaling
28. Direct binding of G-protein βγ complex to voltage-dependent calcium channels
29. Ras-dependent mitogen-activated protein kinase activation by G protein-coupled receptors. Convergence of Gi- and Gq-mediated pathways on calcium/calmodulin, Pyk2 and Src kinase
30. Complement activation in atherosclerosis
31. Immune mechanisms in atherogenesis
32. Immunity and inflammation in the pathogenesis of atherosclerosis
33. Cytokine, immuno-inflammatory response and atherosclerosis
34. Polyclonal origin of T lymphocytes in human atherosclerotic plaque
35. Cytokines and growth factors in atherogenesis
36. Immunoglobulins and complement components in human aortic atherosclerotic intima
37. Immunohistochemical localization of C5b-9, S-protein, C3d and apolipoprotein B in human arterial tissues with atherosclerosis
38. Quantitative evaluation of terminal C5b-9 complement complex by ELISA in human atherosclerotic arteries
39. Vlaicu R: Cells carrying C5b-9 complement complexes in human atherosclerotic wall
40. Decay-accelerating factor regulates complement-mediated damage in the human atherosclerotic wall
41. Tumor necrosis factor-alpha in human arterial wall with atherosclerosis
42. On the reduced atherogenic effect of cholesterol feeding on rabbits with congenital complement C6 deficiency
43. Prelesional complement activation in experimental atherosclerosis. Terminal C5b-9 complement deposition coincides with cholesterol accumulation in the aortic intima of hypercholesterolemic rabbits
44. Immunoelectron-microscopic localization of the terminal C5b-9 complement complex in human atherosclerotic fibrous plaque
45. Interleukin-6 and interleukin-8 protein and gene expression in human arterial atherosclerotic wall
46. Induction of cellular procoagulant activity by the membrane attack complex of complement
47. Complement C5b-9 increases plasminogen binding and activation on human endothelial cells
48. The cytolytic inactive terminal complement complex activates endothelial cells to express adhesion molecules and tissue factor procoagulant activity
49. Tyrosine phosphorylation and activation of Janus kinase 1 and STAT3 by sublytic C5b-9 complement complex in aortic endothelial cells
50. Activation of STAT3 by sublytic C5b-9 in human aortic endothelial cells induces cell cycle
51. Regulation of differentiation of vascular smooth muscle cells
52. Growth factors, proto-oncogenes, and plasticity of the cardiac phenotype
53. The implications of angiogenesis for the biology and therapy of cancer metastasis
54. Pharmacology of smooth muscle cell replication
55. Sublytic C5b-9 induces proliferation of human aortic smooth muscle cells. Role of mitogen activated protein kinase and phosphatidylinositol 3-kinase
56. Principles of CDK regulation
57. Fibrillar collagen inhibits arterial smooth muscle proliferation through regulation of Cdk2 inhibitors
58. G1 phase progression: Cycling on cue
59. p21 is a universal inhibitor of cyclin kinases
60. WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis
61. Thrombin receptor activation elicits rapid protein tyrosine phosphorylation and stimulation of the Raf-1/MAP kinase pathway preceding delayed mitogenesis in cultured rat aortic smooth muscle cells
62. Acute hypertension activates mitogen activated protein kinases in arterial wall
63. The expression and function of G proteins in experimental intimal hyperplasia
64. Activation of mitogen-activated protein kinases by arachidonic acid and its metabolites in vascular smooth muscle cells
65. Lactosylceramide stimulates Ras- loading, kinases (MEK, Raf), p44 mitogen-activated protein kinase, and c-fos expression in human aortic smooth muscle cells